| 0 | 💬 0 |
FcRH5xCD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial.
(nature.com)
|
Nature Medicine 2026-07-22 | #immunotherapy #myeloma #bispecific-antibodies #clinical trial #oncology | |
| 0 | 💬 0 |
Multiscale Higher-Order Molecular Simplicial Complex Embedding for Drug Response Prediction.
(academic.oup.com)
|
Bioinformatics 2026-07-22 | #drug response #deep learning #topology #oncology |